These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17945006)

  • 1. Intrinsic androgen-dependent gene expression patterns revealed by comparison of genital fibroblasts from normal males and individuals with complete and partial androgen insensitivity syndrome.
    Holterhus PM; Deppe U; Werner R; Richter-Unruh A; Bebermeier JH; Wünsch L; Krege S; Schweikert HU; Demeter J; Riepe F; Hiort O; Brooks JD
    BMC Genomics; 2007 Oct; 8():376. PubMed ID: 17945006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential gene-expression patterns in genital fibroblasts of normal males and 46,XY females with androgen insensitivity syndrome: evidence for early programming involving the androgen receptor.
    Holterhus PM; Hiort O; Demeter J; Brown PO; Brooks JD
    Genome Biol; 2003; 4(6):R37. PubMed ID: 12801411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of IGF-II and its binding protein, IGF-binding protein-2, in genital skin fibroblasts of patients with complete androgen insensitivity syndrome compared with normally virilized males.
    Elmlinger MW; Mayer I; Schnabel D; Schuett BS; Diesing D; Romalo G; Wollmann HA; Weidemann W; Spindler KD; Ranke MB; Schweikert HU
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4741-6. PubMed ID: 11600534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein D (APOD) is a putative biomarker of androgen receptor function in androgen insensitivity syndrome.
    Appari M; Werner R; Wünsch L; Cario G; Demeter J; Hiort O; Riepe F; Brooks JD; Holterhus PM
    J Mol Med (Berl); 2009 Jun; 87(6):623-32. PubMed ID: 19330472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen binding in nuclear matrix of human genital skin fibroblasts from patients with androgen insensitivity syndrome.
    Brown TR; Migeon CJ
    J Clin Endocrinol Metab; 1986 Mar; 62(3):542-50. PubMed ID: 3944238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen dependent stimulation of aromatase activity in genital skin fibroblasts from normals and patients with androgen insensitivity.
    Stillman SC; Evans BA; Hughes IA
    Clin Endocrinol (Oxf); 1991 Dec; 35(6):533-8. PubMed ID: 1769135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced expression and normal nucleotide sequence of androgen receptor gene coding and promoter regions in a family with partial androgen insensitivity syndrome.
    Choong CS; Sturm MJ; Strophair JA; McCulloch RK; Hurley DM
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):281-8. PubMed ID: 9156036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of androgen insensitivity.
    Brinkmann AO
    Mol Cell Endocrinol; 2001 Jun; 179(1-2):105-9. PubMed ID: 11420135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete androgen insensitivity syndrome characterized by increased concentration of a normal androgen receptor in genital skin fibroblasts.
    Hughes IA; Evans BA
    J Clin Endocrinol Metab; 1986 Aug; 63(2):309-15. PubMed ID: 3088020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor function links human sexual dimorphism to DNA methylation.
    Ammerpohl O; Bens S; Appari M; Werner R; Korn B; Drop SL; Verheijen F; van der Zwan Y; Bunch T; Hughes I; Cools M; Riepe FG; Hiort O; Siebert R; Holterhus PM
    PLoS One; 2013; 8(9):e73288. PubMed ID: 24023855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and biochemical investigations and molecular analysis of subjects with mutations in the androgen receptor gene.
    Weidemann W; Linck B; Haupt H; Mentrup B; Romalo G; Stockklauser K; Brinkmann AO; Schweikert HU; Spindler KD
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):733-9. PubMed ID: 9039340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, hormonal and genetic characteristics of androgen insensitivity syndrome in 39 Chinese patients.
    Liu Q; Yin X; Li P
    Reprod Biol Endocrinol; 2020 Apr; 18(1):34. PubMed ID: 32345305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genital skin fibroblasts (GF) of patients with androgen insensitivity syndrome express higher insulin-like growth factor binding protein (IGFBP)-2, -3 and -5 than GF of normally virilized males.
    Diesing D; Elmlinger MW; Schuett BS; Weidemann W; Romalo G; Schweikert HU; Spindler KD; Ranke MB
    Horm Res; 2003; 60(2):73-8. PubMed ID: 12876417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete androgen insensitivity without Wolffian duct development: the AR-A form of the androgen receptor is not sufficient for male genital development.
    Barbaro M; Oscarson M; Almskog I; Hamberg H; Wedell A
    Clin Endocrinol (Oxf); 2007 Jun; 66(6):822-6. PubMed ID: 17408421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor mutations are associated with altered epigenomic programming as evidenced by HOXA5 methylation.
    Bens S; Ammerpohl O; Martin-Subero JI; Appari M; Richter J; Hiort O; Werner R; Riepe FG; Siebert R; Holterhus PM
    Sex Dev; 2011; 5(2):70-6. PubMed ID: 21311178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype versus phenotype in families with androgen insensitivity syndrome.
    Boehmer AL; Brinkmann O; Brüggenwirth H; van Assendelft C; Otten BJ; Verleun-Mooijman MC; Niermeijer MF; Brunner HG; Rouwé CW; Waelkens JJ; Oostdijk W; Kleijer WJ; van der Kwast TH; de Vroede MA; Drop SL
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4151-60. PubMed ID: 11549642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced Androgen Receptor Expression in Genital Skin Fibroblasts From Patients With 45,X/46,XY Mosaicism.
    Hornig NC; Demiri J; Rodens P; Murga Penas EM; Caliebe A; Eckstein AK; Schweikert HU; Audi L; Hiort O; Werner R; Kulle AE; Ammerpohl O; Holterhus PM
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4630-4638. PubMed ID: 31180485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of mutant androgen receptors causing partial androgen insensitivity syndrome.
    De Bellis A; Quigley CA; Marschke KB; el-Awady MK; Lane MV; Smith EP; Sar M; Wilson EM; French FS
    J Clin Endocrinol Metab; 1994 Mar; 78(3):513-22. PubMed ID: 8126121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydrotestosterone induces minor transcriptional alterations in genital skin fibroblasts of children with and without androgen insensitivity.
    Tanase-Nakao K; Mizuno K; Hayashi Y; Kojima Y; Hara M; Matsumoto K; Matsubara Y; Igarashi M; Miyado M; Fukami M
    Endocr J; 2019 Apr; 66(4):387-393. PubMed ID: 30787207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic variation in a family with partial androgen insensitivity syndrome explained by differences in 5alpha dihydrotestosterone availability.
    Boehmer AL; Brinkmann AO; Nijman RM; Verleun-Mooijman MC; de Ruiter P; Niermeijer MF; Drop SL
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1240-6. PubMed ID: 11238515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.